U.S. Semiconductors Stock News

Nektar Therapeutics recently completed an upsized follow-on equity offering of about US$400.00 million in common stock and pre-funded warrants to help fund research, clinical development, and manufacturing for its pipeline. This capital raise closely followed positive 36-week maintenance data from the Phase 2b REZOLVE-AD trial of rezpegaldesleukin in moderate-to-severe atopic dermatitis, which showed durable disease control with both monthly and quarterly dosing and a consistent safety...

Advanced Energy Industries (AEIS) has just closed out FY 2025 with fourth quarter revenue of US$489.4 million and basic EPS of US$1.40, with trailing twelve month revenue of US$1.8 billion and EPS of US$3.97 framing the full year picture. The company has seen quarterly revenue move from US$374.2 million in Q3 2024 to US$489.4 million in Q4 2025, while basic EPS has shifted from a loss of US$0.38 in Q3 2024 to US$1.40 in Q4 2025 and US$3.97 on a trailing basis, setting up a results season...

Baker Hughes Company's ( NASDAQ:BKR ) stock was strong despite it releasing a soft earnings report last week. However...

Brinker International recently reported a strong Q2 FY2026, with revenue and operating income ahead of expectations, driven by Chili’s 8.6% year-over-year same-store sales growth and a subsequent increase in full-year revenue and EPS guidance. Chili’s brand momentum is also evident in its Margarita of the Month Club, launched after selling nearly 30 million margaritas in 2025, underscoring customer engagement that may reinforce Brinker's focus on optimizing existing locations. We’ll now...

Teradyne (NasdaqGS:TER) and MultiLane have formed a joint venture focused on advanced testing solutions for AI data centers. The new entity is designed to address demand for high speed testing of AI data center equipment. The partnership combines MultiLane’s specialized test assets with Teradyne’s global customer reach and product portfolio. For investors watching how chip and hardware suppliers respond to AI infrastructure build outs, this move provides a clearer view of where Teradyne is...

If you are wondering whether Caterpillar's current share price really reflects its value, you are not alone. The stock has attracted a lot of attention from investors trying to work out what is already priced in. The share price recently closed at US$775.00, with returns of 12.0% over the past 7 days, 23.1% over the past 30 days, 29.5% year to date and 123.2% over the last year, as well as 227.2% over 3 years and 320.1% over 5 years. Recent news coverage has focused on Caterpillar as a key...

Fifth Third Bancorp (NasdaqGS:FITB) has completed its merger with Comerica Inc., creating the ninth-largest U.S. bank. The combined company has expanded its board size, refreshed leadership and amended bylaws to allow for new preferred stock. Fifth Third has also grown its "Team Fifth Third" NIL program, tying student-athlete partnerships to financial education efforts. For you as an investor, this puts NasdaqGS:FITB in a different peer group, with a footprint that now spans more markets...

Ultragenyx Pharmaceutical (RARE) is back in focus after releasing long term UX111 gene therapy data in Sanfilippo syndrome type A. This is tied directly to a fresh FDA BLA resubmission that follows earlier clinical and legal setbacks. See our latest analysis for Ultragenyx Pharmaceutical. Against this backdrop, Ultragenyx’s 1-day share price return of a 1.32% decline and 7-day share price return of a 3.28% decline sit alongside a 90-day share price return of a 27.42% decline and a 1-year...

If you are wondering whether BlackRock’s current share price lines up with its underlying worth, you are not alone. That is exactly what this article is here to unpack. Over the past year, the stock has returned 13.5%, with a 0.6% gain over the last 7 days, a 0.6% decline over 30 days, and a 0.2% decline year to date from a last close of US$1,082.88. Recent coverage has centered on BlackRock’s role as one of the largest global asset managers and its position in long term investment themes,...

If you are wondering whether Noble's current share price lines up with its underlying worth, you are not alone. This article is here to unpack that question clearly. Noble's share price recently closed at US$44.06, with returns of 14.5% over 7 days, 47.3% over 30 days, 51.9% year to date, and 55.6% over 1 year, which has caught the attention of many investors thinking about growth potential and changing risk perceptions. Recent coverage of Noble has highlighted the stock's role in the energy...

Pegasystems (PEGA) capped FY 2025 with fourth quarter revenue of US$504.3 million and basic EPS of US$1.38, alongside trailing twelve month revenue of US$1.75 billion and EPS of US$2.30, set against earnings growth of 296.7% over the past year. Over recent periods, the company has seen quarterly revenue move between US$325.1 million and US$504.3 million and basic EPS range from a loss of US$0.08 to a gain of US$1.38, while trailing net profit margin increased from 6.6% to 22.5%. For...

If you are wondering whether Twilio’s current share price lines up with its underlying worth, you are not alone. This article is here to unpack the numbers in a clear, practical way. Twilio’s stock closed at US$110.44, with returns of a 1.3% decline over 7 days, a 16.3% decline over 30 days, a 20.2% decline year to date, a 23.6% decline over 1 year and a 67.2% gain over 3 years, alongside a 73.2% decline over 5 years. Taken together, these figures suggest investors have been repeatedly...

If you are trying to figure out whether AST SpaceMobile is priced attractively or already baking in big expectations, you are in the right place for a clear look at its valuation. The share price recently closed at US$96.92, with returns of 16.1% year to date and 251.0% over the last year, even after a 6.4% decline over the past week and a 1.5% decline over the last month. Recent news has focused on AST SpaceMobile's efforts to build a space based cellular broadband network, along with...

MoonLake Immunotherapeutics: Recent Returns Put Volatility in Focus MoonLake Immunotherapeutics (MLTX) has seen mixed share performance recently, with a 1 day return of 1.1%, a 7 day gain of 5.1%, a month decline of 12.7%, and a past 3 months gain of 25.7%. See our latest analysis for MoonLake Immunotherapeutics. At a share price of $15.79, MoonLake Immunotherapeutics has paired strong recent share price momentum, with a 90 day share price return of 25.7% and a year to date share price return...

If you are wondering whether D-Wave Quantum's share price still lines up with its underlying worth, this article will help you weigh what you are really paying for. The stock closed at US$19.64, with a 7 day return of a 2.3% decline, a 30 day return of a 31.8% decline and a year to date return of a 30.2% decline, set against a 1 year return of 225.2% and a very large 3 year gain. Recent coverage around D-Wave Quantum has focused on its position in quantum computing and how investors are...

KeyCorp (NYSE:KEY) and HoldCo Asset Management agreed to halt acquisitions, initiate a US$300 million stock buyback, and add a new independent director. The agreement heads off a potential proxy fight and reflects active engagement between the bank and one of its shareholders. KeyCorp is a regional banking group focused on lending, deposit gathering, and related financial services, an area that has been under close investor scrutiny after industry stresses and tighter regulation...

Devon Energy and Coterra Energy (NYSE:CTRA) have entered into a definitive merger agreement, forming a combined shale operator with an estimated enterprise value of about US$58b. The deal includes changes to the management team and board structure for the combined company. The transaction terms feature higher dividends for shareholders and a sizeable share repurchase program. An investigation is underway into whether Coterra's Board met its fiduciary duties in agreeing to the...

Textron’s new buyback and board appointment in focus Textron (TXT) has drawn fresh attention after its Board authorized a new share repurchase program for up to 25,000,000 shares, alongside the upcoming addition of finance veteran Cristina Méndez to its Board of Directors. See our latest analysis for Textron. At a share price of $97.28, Textron has seen a 7.22% 7 day share price return and an 11.75% year to date share price return. Its 1 year total shareholder return of 33.76% and 5 year...

If you are wondering whether Copart's current share price really matches its underlying worth, you are not alone. That is exactly what this article will help you unpack. Over the past year the stock is down 33.1%, even though it is up 4.6% year to date. This can change how investors think about both its growth potential and its risk profile. Recent headlines around Copart have focused on its role in vehicle remarketing and salvage auctions, as investors watch how demand for used and damaged...

Nektar Therapeutics ( NASDAQ:NKTR ) shares have had a really impressive month, gaining 81% after a shaky period...

The board of Community Financial System, Inc. ( NYSE:CBU ) has announced that it will pay a dividend of $0.47 per share...

Black Hills Corporation ( NYSE:BKH ) is about to trade ex-dividend in the next 4 days. The ex-dividend date occurs one...

Shareholders appeared unconcerned with Bio-Techne Corporation's ( NASDAQ:TECH ) lackluster earnings report last week...

NovoCure Limited ( NASDAQ:NVCR ) shareholders won't be pleased to see that the share price has had a very rough month...